What is the stent thrombosis?

Sent thrombosis is a dangerous condition that occurs when a blood clot is formed on the stent. It has symptoms similar to heart thrombosis of any kind and is classified until it occurs after the stent is located: very early or the first month, the first or first year and late or after a year. A person who has a stent should be aware of sudden feeling of fatigue, inability to take a breath, easy exhaustion or angina. Other symptoms may include a full myocardial infarction or heart attack. People could have severe chest or stomach pain, breathing problems, nausea, pain that shoots the arm or any loss of consciousness. This second set of symptoms suggests that emergency assistance is required and the first set should be reported immediately by the doctor. Doctors can also help patients by giving them accurate instructions on what symptoms they require attention.

the stents have been eased to maintain openingThe blood vessels that have been narrowed or closed and have helped to improve heart function for many patients. The risk of restenosis or re -disruption of the blood vessel has led to the development of stents of eluting pharmaceuticals (DES) that released drugs. Although these effectively reduced the risk in one way, they also increased the chances of developing stent thrombosis, especially a year after the stent placement procedure. This was a slight risk with simple mesh stents, especially a year after the placement. When a blood clot is formed either with a mesh or desing, a person is exposed to a serious risk of death due to heart arrest. The medical community continues to study these risks and has specific recommendations on the therapy needed after placing the stent, and although the prospect of stent thrombosis can be a terrible thing to consider for patients, it should also be recognized as a rare phenomenon.

There are instructions for prevention of stent thrombosis. When patients receive stent, usually also take two drugs that reduce aggregation and production of plates. FromThe 2010 drug instructions have changed slightly. Most people have taken aspirin and Plavix®, but now there is evidence that some people do not respond well to it. Instead, additional medicines except Plavix® can be recommended. Antiplate therapy is usually used for at least a year or longer if the patient has a late stent due to increased risk of thrombosis.

There are also instructions for determining which patients make the best candidates for stenting. People with acute coronary syndrome who have symptoms such as chest pain tend to have greater risks for creating blood clots and, according to some studies, about 2.5% of this population will experience blood clots. On the other hand, those with stable cardiac conditions that do not pose that many symptoms have about 1% risk of blood clot problems. This suggestion of the STS stent is a useful early preventive tool and can pose a greater risk for those who have deeper diseases. The risk is also calculated by the type of stent and bothIt has a higher risk than a stent network for the formation of blood clots at a late stage.